WASHINGTON, DC, March 22, 2023 – In a letter sent yesterday to the U.S. Senate Committee on Commerce, Science, and Transportation, The ERISA Industry Committee (ERIC) urged the members to vote no on the Pharmacy Benefit Manager Transparency Act (PBMTA, S. 127), legislation that fails to include employer-focused, comprehensive solutions that would bring clarity and responsibility to the prescription drug supply chain.
Miscellaneous Archives:
The ERISA Industry Committee Refiles Motion for Summary Judgment in NJ WARN Act Lawsuit
Washington, D.C., March 14, 2023 – The ERISA Industry Committee (ERIC) today refiled a motion for summary judgment in its ongoing lawsuit, The ERISA Industry Committee v. Robert Asaro-Angelo, the Commissioner of the New Jersey Department of Labor and Workforce Development. This filing follows the completion of an expedited discovery process ordered by the Court, regarding ERIC’s standing to file the suit.
The ERISA Industry Committee Appoints Melissa Bartlett to Senior Vice President for Health Policy
WASHINGTON, March 2, 2023 – The ERISA Industry Committee (ERIC) announced today that it has appointed Melissa Bartlett as senior vice president for health policy.
The ERISA Industry Committee Opposes SEC “Hard Close” Proposal that Would Create Disadvantages for Retirement Savers
WASHINGTON, February 14, 2023 – The ERISA Industry Committee (ERIC) today submitted comments opposing a U.S. Securities and Exchange Commission (SEC) proposed regulation affecting the operation of most open-end mutual funds.
The ERISA Industry Committee Urges Senate Judiciary Committee to Advance Legislation to Enhance Prescription Drug Competition and Affordability
WASHINGTON, February 8, 2023 – The ERISA Industry Committee (ERIC) urged members of the Senate Committee on the Judiciary in a letter to vote in favor of several bills which would improve transparency, promote competition, and prohibit practices that discourage affordability within the prescription drug market.
The ERISA Industry Urges Congress to Pass the Telehealth Benefit Expansion for Workers Act of 2023
WASHINGTON, February 6, 2023 – The ERISA Industry Committee (ERIC) urged Congress to pass the “Telehealth Benefit Expansion for Workers Act of 2023” (H.R. 824) to allow employers to offer standalone telehealth benefits to all employees, beyond the end of the public health emergency (PHE), in particular those not enrolled in their employer’s medical plan.
The ERISA Industry Committee Cites Concerns with the “Pharmacy Benefit Manager Transparency Act” (S. 127)
WASHINGTON, February 2, 2023 – The ERISA Industry Committee (ERIC) today submitted a letter to Senate champions of the “Pharmacy Benefit Manager Transparency Act” (PBMTA, S. 127) outlining serious concerns with the legislation.
Employers Work to Expand Mental & Behavioral Health Care Offerings but Need Congress’ Help to do More
Providing high quality affordable, and accessible mental and behavioral health care for employees and their families is a top priority for large employers. As laid out in ERIC’s 2021 mental health report, employers responded to the increased need for care exasperated by the pandemic by expanding their benefit offerings; and they continue to work to improve access and quality in all aspects of the health care system.
ERIC Supports Congressional Efforts to Expand Retirement Savings Opportunities for Workers
ERIC is working with lawmakers to expand opportunities to help workers save for retirement and employers efficiently administer benefit plans. Today, ERIC submitted a statement for the record to the U.S. Senate Health, Education, Labor & Pensions Committee for its hearing titled “Rise and Shine: Improving Retirement and Enhancing Savings.”
American Workers Not Responsible for Shouldering Medicare Prescription Drug Costs
ERIC provided a statement for the record to the U.S. Senate Committee on Finance ahead of today’s hearing titled “Prescription Drug Price Inflation: An Urgent Need to Lower Drug Prices in Medicare.”